Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
12 2023
Historique:
received: 18 01 2023
revised: 25 07 2023
accepted: 02 08 2023
medline: 20 11 2023
pubmed: 22 9 2023
entrez: 21 9 2023
Statut: ppublish

Résumé

The presence of tumor-infiltrating lymphocytes (TILs) is associated with a favorable prognosis of primary melanoma (PM). Recently, artificial intelligence (AI)-based approach in digital pathology was proposed for the standardized assessment of TILs on hematoxylin and eosin-stained whole slide images (WSIs). Herein, the study applied a new convolution neural network (CNN) analysis of PM WSIs to automatically assess the infiltration of TILs and extract a TIL score. A CNN was trained and validated in a retrospective cohort of 307 PMs including a training set (237 WSIs, 57,758 patches) and an independent testing set (70 WSIs, 29,533 patches). An AI-based TIL density index (AI-TIL) was identified after the classification of tumor patches by the presence or absence of TILs. The proposed CNN showed high performance in recognizing TILs in PM WSIs, showing 100% specificity and sensitivity on the testing set. The AI-based TIL index correlated with conventional TIL evaluation and clinical outcome. The AI-TIL index was an independent prognostic marker associated directly with a favorable prognosis. A fully automated and standardized AI-TIL appeared to be superior to conventional methods at differentiating the PM clinical outcome. Further studies are required to develop an easy-to-use tool to assist pathologists to assess TILs in the clinical evaluation of solid tumors.

Identifiants

pubmed: 37734590
pii: S0002-9440(23)00324-3
doi: 10.1016/j.ajpath.2023.08.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2099-2110

Informations de copyright

Copyright © 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Filippo Ugolini (F)

Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy.

Francesco De Logu (F)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Luigi Francesco Iannone (LF)

Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.

Francesca Brutti (F)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Sara Simi (S)

Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy.

Vincenza Maio (V)

Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy.

Vincenzo de Giorgi (V)

Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.

Anna Maria di Giacomo (A)

Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University of Siena, Siena, Italy.

Clelia Miracco (C)

Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University of Siena, Siena, Italy.

Francesco Federico (F)

Institute of Pathology, Sacred Heart Catholic University, Rome, Italy.

Ketty Peris (K)

Institute of Dermatology, Sacred Heart Catholic University, Rome, Italy.

Giuseppe Palmieri (G)

Unit of Cancer Genetics, Institute of Genetic and Biomedical Research, National Research Council, Sassari, Italy.

Antonio Cossu (A)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Mario Mandalà (M)

Oncology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Daniela Massi (D)

Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy.

Marco Laurino (M)

Institute of Clinical Physiology, National Research Council, Pisa, Italy. Electronic address: marco.laurino@cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH